Revance Therapeutics Inc (Inactive Symbol)

YTD Price Probability

No random walk data for 2024

Default prediction by Z-Score (what's this?).

Z Score :

10.7469

Sector

Industry

View the other companies in the same industry : Bio Therapeutic Drugs

Alternative Z-Scores designed for non-public companies (i.e. take these with a grain of salt):

For manufacuring companies:

Z' Score :

7.6934

Sector Industry

For non-manufacturing companies:

Z'' Score :

20.9101

Sector Industry

Fundamental Analysis metrics & ratios (what's this?).

Date of financial statements used: 2017-03-31
Book Value:	$178.7M	Internal Value:	$178.7M	Working Capital:	$173.4M
Debt to Asset Ratio:	0.147	Current Ratio:	8.213	Turnover Ratio:	N/A
Net Margin:	-38800%	EPS:	-3.815	P/E ratio:	-5.282
P/B ratio:	3.212	ROE:	-60.8%	ROA:	-51.9%

Symbol: RVNC

Market Cap: $573.9M

Exchange: NASDAQ

Data Since: 2015-01-02